SFDA BE GL v3.1 (also GCC?) [Regulatives / Guidelines]

posted by wienui  – Germany/Oman, 2023-07-04 19:35 (717 d 23:55 ago) – Posting: # 23651
Views: 2,921

(edited on 2023-07-04 19:58)

❝ Dear all – and especially my dearest friend Osama!


My dear friend Helmut,
Sorry for not responding early, due to personal and health conditions.

❝ Now for the question: Is this guideline implemented only in Saudi Arabia or in all members of the Gulf Cooperation Council as well?


Yes, as Clarified by khaledazeid , it is applied in all GCC member states. Unfortunately, there is no reference, that we could refer to, But it is totally sure that all GCC members are applying this GL.


By the way, Regarding to the inflation of Type I Error for HVD(P)'s especially if the estimated CVwR >40%, lower limit <75%, upper limit >133%, it was called several times for the amendment of this point in the GCC GL since 2016 and as a result, there were clear instructions that the assessor has to follow the EMA in this matter but officially it still there in the GL.

Cheers,
Osama

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,672 registered users;
53 visitors (0 registered, 53 guests [including 14 identified bots]).
Forum time: 19:30 CEST (Europe/Vienna)

Medical researches can be divided into two sorts:
those who think that meta is better and those
who believe that pooling is fooling.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5